BIO-EUROPE

BIO-EUROPE is an international partnering conference for the global biotechnology industry, designed to foster business development among pharmaceutical, financial, and biotechnology companies. As one of the most influential events in the global biotechnology sector, BIO-EUROPE annually gathers biopharmaceutical executives, investors, and innovators from around the world to discuss cutting-edge industry trends and seek collaboration opportunities. The conference provides an efficient platform for exchange through intensive partnering meetings, keynote speeches, panel discussions, and company presentations. BIO-EUROPE is not only an important venue for new drug discovery, technology licensing, and investment and M&A but also a barometer for discerning the future direction of the biotechnology industry. The conference is dedicated to promoting the translation and application of biotechnological innovations and accelerating the marketization of new therapies and technologies. Its unique partnering system enables participants to precisely connect with potential partners, significantly enhancing the efficiency and success rate of business negotiations. Held annually in major European cities, it attracts numerous industry leaders and decision-makers, solidifying its leading position in global biotechnology collaboration. The target audience includes, but is not limited to, heads of R&D, business development, and strategic partnering departments from biopharmaceutical companies, investment managers from venture capital firms and private equity funds, as well as founders, scientists, and technical experts from biotechnology startups.

BIO-EUROPE's exhibition scope and partnering areas cover various aspects of the biotechnology industry, including but not limited to: small molecule drug discovery, large molecule biologics, cell and gene therapy, vaccine development, diagnostic technologies, biosimilars, orphan drugs, precision medicine, drug delivery systems, bioprocess and manufacturing, contract research and manufacturing services (CDMO/CRO), bioinformatics, artificial intelligence in drug discovery, genomics, proteomics, metabolomics, biomarker discovery and validation, clinical trial services, medical devices and diagnostic equipment, digital health solutions, biotechnology investment and financing, intellectual property and technology licensing, biotech parks and incubators, laboratory equipment and consumables, biopharmaceutical supply chain management, regulatory affairs and compliance, market access strategies, patient support programs, bioethics and social responsibility.

No fee information available. Please contact us for a quote.